BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 32331793)

  • 21. Quantitative perfusion analysis of hepatocellular carcinoma using dynamic contrast enhanced ultrasound (CEUS) to determine tumor microvascularization.
    Schaible J; Stroszczynski C; Beyer LP; Jung EM
    Clin Hemorheol Microcirc; 2019; 73(1):95-104. PubMed ID: 31561349
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Early diagnosis of small hepatocellular carcinoma by new contrast-enhanced ultrasound technique].
    Chen MH; Dai Y; Yan K; Fan ZH; Wu W; Wang YB; Yin SS; Yang W; Li JY
    Beijing Da Xue Xue Bao Yi Xue Ban; 2005 Oct; 37(5):458-62. PubMed ID: 16224512
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Impact of Hepatic Steatosis on Disease-Free Survival in Patients with Non-B Non-C Hepatocellular Carcinoma Undergoing Hepatic Resection.
    Nishio T; Hatano E; Sakurai T; Taura K; Okuno M; Kasai Y; Seo S; Yasuchika K; Mori A; Kaido T; Uemoto S
    Ann Surg Oncol; 2015 Jul; 22(7):2226-34. PubMed ID: 25395147
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Contrast-enhanced ultrasound of hepatocarcinogenesis in liver cirrhosis.
    Wu W; Chen MH; Sun M; Yan K; Yang W; Li JY
    Chin Med J (Engl); 2012 Sep; 125(17):3104-9. PubMed ID: 22932189
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Contrast-enhanced ultrasound features of hepatocellular carcinoma not detected during the screening procedure.
    Dong Y; Wang WP; Mao F; Dietrich C
    Z Gastroenterol; 2017 Aug; 55(8):748-753. PubMed ID: 28799151
    [No Abstract]   [Full Text] [Related]  

  • 26. Outcomes after hepatectomy of patients with positive HBcAb Non-B Non-C hepatocellular carcinoma compared to overt hepatitis B virus hepatocellular carcinoma.
    Wu SS; Shan QY; Xie WX; Chen B; Huang Y; Guo Y; Xie XY; Lu MD; Peng BG; Kuang M; Shen SL; Wang W
    Clin Transl Oncol; 2020 Mar; 22(3):401-410. PubMed ID: 31172445
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Application of imaging fusion combining contrast-enhanced ultrasound and magnetic resonance imaging in detection of hepatic cellular carcinomas undetectable by conventional ultrasound.
    Dong Y; Wang WP; Mao F; Ji ZB; Huang BJ
    J Gastroenterol Hepatol; 2016 Apr; 31(4):822-8. PubMed ID: 26480287
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Role of Contrast-Enhanced Ultrasound as a Second-Line Diagnostic Modality in Noninvasive Diagnostic Algorithms for Hepatocellular Carcinoma.
    Kang HJ; Lee JM; Yoon JH; Han JK
    Korean J Radiol; 2021 Mar; 22(3):354-365. PubMed ID: 33236540
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparison of clinicopathologic characteristics among patients with HBV-positive, HCV-positive and Non-B Non-C hepatocellular carcinoma after hepatectomy: a systematic review and meta-analysis.
    Yu B; Zhi X; Li Q; Li T; Chen Z
    BMC Gastroenterol; 2023 Aug; 23(1):289. PubMed ID: 37612653
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Primary hepatic epithelioid angiomyolipoma: a small case series.
    Zhu J; Wang G; Sun G; Xie B; Xiao W; Li Y
    ANZ J Surg; 2022 Jul; 92(7-8):1803-1808. PubMed ID: 35578781
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Triphasic and epithelioid minimal fat renal angiomyolipoma and clear cell renal cell carcinoma: qualitative and quantitative CEUS characteristics and distinguishing features.
    Lu Q; Li CX; Huang BJ; Xue LY; Wang WP
    Abdom Imaging; 2015 Feb; 40(2):333-42. PubMed ID: 25139641
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A comparison of the surgical outcomes among patients with HBV-positive, HCV-positive, and non-B non-C hepatocellular carcinoma: a nationwide study of 11,950 patients.
    Utsunomiya T; Shimada M; Kudo M; Ichida T; Matsui O; Izumi N; Matsuyama Y; Sakamoto M; Nakashima O; Ku Y; Takayama T; Kokudo N;
    Ann Surg; 2015 Mar; 261(3):513-20. PubMed ID: 25072437
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Imaging Features on Contrast-Enhanced Ultrasound and Clinical Characteristics of Hepatitis B Virus-Related Combined Hepatocellular-Cholangiocarcinoma: Comparison with Hepatitis B Virus-Related Hepatocellular Carcinoma.
    Ye J; Xie X; Liu B; Zhang X; Wang W; Huang X; Lu M; Huang G
    Ultrasound Med Biol; 2017 Nov; 43(11):2530-2536. PubMed ID: 28847498
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hepatic Angiomyolipoma: Clinical Features and Imaging Findings of Quantitative Contrast-Enhanced Ultrasound Perfusion Analysis and Magnetic Resonance Imaging.
    Huang Z; Zhou P; Li S; Li K
    J Ultrasound Med; 2020 Nov; 39(11):2111-2122. PubMed ID: 32383807
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Differential Diagnosis of Arterial Phase Enhanced Hepatic Inflammatory Lesions and Hepatocellular Carcinomas with Contrast-enhanced Ultrasound.
    Yang W; Yan K; Wang S; Dai Y; Wu W; Yin SS; Chen MH
    Ultrasound Med Biol; 2016 Jan; 42(1):82-91. PubMed ID: 26456578
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Characterization of Early Hepatocellular Carcinoma and High-Grade Dysplastic Nodules on Contrast-Enhanced Ultrasound: Correlation With Histopathologic Findings.
    Fan PL; Xia HS; Ding H; Dong Y; Chen LL; Wang WP
    J Ultrasound Med; 2020 Sep; 39(9):1799-1808. PubMed ID: 32378794
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Utility of contrast-enhanced ultrasound with perflubutane for diagnosing the macroscopic type of small nodular hepatocellular carcinomas.
    Tada T; Kumada T; Toyoda H; Ito T; Sone Y; Kaneoka Y; Maeda A; Okuda S; Otobe K; Takahashi K
    Eur Radiol; 2014 Sep; 24(9):2157-66. PubMed ID: 24952601
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Contrast enhanced ultrasound for the characterization of hepatocellular carcinoma.
    Martie A; Sporea I; Popescu A; Sirli R; Dănilă M; Serban C; Ardelean M; Bota S; Sendroiu M; Chisevescu D
    Med Ultrason; 2011 Jun; 13(2):108-13. PubMed ID: 21655536
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Contrast-enhanced sonography in the diagnosis of small hepatocellular carcinoma < or =2 cm.
    Xu HX; Xie XY; Lu MD; Liu GJ; Xu ZF; Zheng YL; Liang JY; Chen LD
    J Clin Ultrasound; 2008 Jun; 36(5):257-66. PubMed ID: 18088056
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The role of contrast-enhanced ultrasound in planning treatment protocols for hepatocellular carcinoma before radiofrequency ablation.
    Chen MH; Yang W; Yan K; Dai Y; Wu W; Fan ZH; Callstrom MR; Charboneau JW
    Clin Radiol; 2007 Aug; 62(8):752-60. PubMed ID: 17604763
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.